GraniteShares Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,974
Closed -$1.51M 105
2025
Q3
$1.51M Sell
17,974
-222
-1% -$18.3K 0.87% 47
2025
Q2
$1.44M Buy
18,196
+791
+5% +$62.9K 0.89% 48
2025
Q1
$1.56M Buy
17,405
+173
+1% +$16.2K 1% 47
2024
Q4
$1.71M Buy
+17,232
New +$1.78M 1.09% 48
2023
Q3
Sell
-7,388
Closed -$853K 125
2023
Q2
$853K Sell
7,388
-209
-3% -$23.7K 0.77% 54
2023
Q1
$808K Buy
7,597
+72
+1% +$7.77K 0.71% 56
2022
Q4
$835K Sell
7,525
-1,598
-18% -$163K 0.69% 36
2022
Q3
$785K Sell
9,123
-995
-10% -$88.8K 0.64% 44
2022
Q2
$922K Sell
10,118
-1,156
-10% -$102K 0.68% 34
2022
Q1
$925K Sell
11,274
-697
-6% -$55K 0.5% 49
2021
Q4
$917K Buy
+11,971
New +$953K 0.42% 50

Other funds holding MRK

GraniteShares Advisors's MRK Position: Q4 2025 in Review

GraniteShares Advisors sold out of Merck (MRK) in Q4 2025, closing a stake of 17,974 shares — an estimated $1.51M sold.

GraniteShares Advisors first reported a position in MRK in Q4 2021 and held it in 11 quarters. The position peaked at $1.71M in Q4 2024. 3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • GraniteShares Advisors reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • GraniteShares Advisors sold 17,974 Merck shares in Q4 2025, an estimated $1.51M.
  • GraniteShares Advisors first reported a position in Merck in Q4 2021 and held it in 11 quarters.
  • GraniteShares Advisors's Merck position peaked at $1.71M in Q4 2024.
  • 3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on GraniteShares Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.